(Q41837819)

12 October 2017

Severe cutaneous toxicity following treatment with radiotherapy and cetuximab: a case report (English)

1 reference

12 October 2017

1 reference

Arun Azad

1

1 reference

12 October 2017

7 January 2009

1 reference

12 October 2017

1 reference

12 October 2017

2

1 reference

12 October 2017

1

1 reference

12 October 2017

25

1 reference

Creative Commons Attribution 2.0 Generic

12 October 2017

start time

7 January 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1757-1626-2-25

0 references

cites work

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628867

Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628867

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628867

Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628867

Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer.

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628867

Acneiform rash secondary to cetuximab plus head and neck radiotherapy

18 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19128507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19128507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Severe cutaneous reaction during radiation therapy with concurrent cetuximab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19128507

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1757-1626-2-25

1 reference

12 October 2017

1 reference

PMC publication ID

2628867

12 October 2017

PubMed publication ID

19128507

1 reference

PMC publication ID

2628867